CABA Chart
See on advanced chart >
About
Cabaletta Bio, Inc. were incorporated under the laws of the State of Delaware in April 2017. The company is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies that have the potential to provide a...
Read More
- HighlightA clinical-stage biotech company focused on targeted cell therapies for autoimmune diseases
- ExchangeNASDAQ
- Listing Date10/25/2019
- Established DateInvalid Date
- Full-time Employees101
- Address2929 Arch Street Suite 600 Philadelphia PA 19104
- Tel1-267-7593100
- Website
- Fiscal Year End Date12/31
- Security TypeCommon Stock
Industry
Biotechnology